Hydrophobic Interaction Chromatography Market Analysis

Hydrophobic Interaction Chromatography Segmentation

Sample (Monoclonal Antibodies, Vaccines)

The monoclonal antibodies segment is estimated to hold 38% share of the global hydrophobic interaction chromatography market by 2036. There has been a significant increase in cases of cancer, autoimmune diseases, inflammatory disorders, and Alzheimer. All these diseases have increased the demand for monoclonal antibodies and higher approvals of mAB will drive the segment growth. For instance, in 2022, the FDA granted an emergency use authorization (EUA) for bebtelovimab, a novel monoclonal antibody for the treatment of COVID-19. Monoclonal antibodies are present in different isoforms, that have varying hydrophobic properties, HIC helps in separating and identifying these isoforms. This data generated after performing HIC can be used to assess the stability and consistency of the mAB products.

Products & Services (Resin, Columns, Buffer, Services)

Hydrophobic interaction chromatography market from the resin segment is expected to garner a significant share of around 40% in the year 2036. Continuous advancements in HIC resin technology are leading the segment’s growth. The development of improved resin has enhanced the performance characteristics. The advanced properties include better resolution, improved selectivity, enhances stability, higher binding capacities, and others.

Our in-depth analysis of the market includes the following segments:

Sample	Monoclonal Antibodies Vaccines
Product & Services	Resin Columns Buffer Services
End User	Pharmaceutical Companies CROs & CMOs Research Institutes

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of hydrophobic interaction chromatography is assessed at USD 1.69 Billion.

The hydrophobic interaction chromatography market size was valued at USD 1.54 Billion in 2023 and is likely to reach USD 5.62 Billion by the end of 2036, registering around 10.5% CAGR during the forecast period i.e., between 2024-2036. Rising development of vaccines and higher investment in biopharma industries are the major factors driving the market growth.

North America industry is projected to hold 35% of the revenue share by 2036, impelled by growing cases of cancer and autoimmune diseases in the region.

Sunresin New Materials Co., Ltd.Bio-Rad Laboratories, Inc.Thermo Fisher ScientificThe General Electric CompanySartorius AGTosoh Bioscience, Inc.Sepax Technologies, Inc.Merck KGaA.JNC CorporationGeno Technology Inc.

Hydrophobic Interaction Chromatography Market Analysis